Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis

To assess the comparative benefits and harms of different pharmacological interventions in the treatment of chronic HCV infection through a network meta-analysis and to generate rankings of the available pharmacological treatments according to their safety and efficacy.

This is a protocol.